QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kemmis, C. M. Articles by Welsh, J. Search for Related Content PubMed PubMed Citation Articles by Kemmis, C. M. Articles by Welsh, J.

---

Biochemical, Molecular, and Genetic Mechanisms

Human Mammary Epithelial Cells Express CYP27B1 and Are Growth Inhibited by 25-Hydroxyvitamin D-3, the Major Circulating Form of Vitamin D-3¹

Department of Biological Sciences, University of Notre Dame, Notre Dame, IN 46556

³ To whom correspondence should be addressed. E-mail: jwelsh3{at}nd.edu.

1,25-dihydroxycholecalciferol [1,25(OH)₂D₃], the active form of cholecalciferol, is a negative growth regulator of breast cancer cells. CYP27B1 is a cytochrome P450-containing hydroxylase expressed in kidney and other tissues that generates 1,25(OH)₂D₃ from an inactive vitamin D precursor 25-hydroxycholecalciferol [25(OH)D₃]. In these studies, we tested the hypothesis that mammary cells express CYP27B1 and locally produce 1,25(OH)₂D₃, which acts in an autocrine manner to regulate cell turnover. Using Western blot and quantitative real-time PCR, CYP27B1 mRNA and protein were detected in immortalized, nontumorigenic human mammary epithelial cell (HMEC) cultures. Furthermore, HMEC cultures were dose dependently growth inhibited by physiological concentrations of 25(OH)D₃, suggesting that CYP27B1 converts this precursor cholecalciferol metabolite to 1,25(OH)₂D₃, the ligand for the vitamin D receptor (VDR). In support of this suggestion, both 1,25(OH)₂D₃ and 25(OH)D₃ transactivated VDR in HMEC cultures, as measured by induction of a vitamin D responsive reporter gene and upregulation of CYP24, an endogenous VDR target gene. No induction of CYP24 by 25(OH)D₃ was observed in mammary cells derived from CYP27B1 null mice. Similar results were observed in 2 independently derived immortalized HMEC lines as well as in primary cultures derived from human breast epithelium. These are the first studies to demonstrate that nontransformed human mammary cells express CYP27B1, that they are growth inhibited by physiologically relevant concentrations of 25(OH)D₃, and that they provide a biological mechanism linking vitamin D status to breast cancer risk.

KEY WORDS: • vitamin D • mammary • breast cancer • CYP27B1

This article has been cited by other articles:

				L. Rejnmark, A. Tietze, P. Vestergaard, L. Buhl, M. Lehbrink, L. Heickendorff, and L. Mosekilde Reduced Prediagnostic 25-Hydroxyvitamin D Levels in Women with Breast Cancer: A Nested Case-Control Study Cancer Epidemiol. Biomarkers Prev., October 1, 2009; 18(10): 2655 - 2660. [Abstract] [Full Text] [PDF]

				M. THILL, D. FISCHER, S. BECKER, T. CORDES, C. DITTMER, K. DIEDRICH, D. SALEHIN, and M. FRIEDRICH Prostaglandin Metabolizing Enzymes in Correlation with Vitamin D Receptor in Benign and Malignant Breast Cell Lines Anticancer Res, September 1, 2009; 29(9): 3619 - 3625. [Abstract] [Full Text] [PDF]

				F. R. Perez-Lopez, P. Chedraui, and J. Haya Review Article: Vitamin D Acquisition and Breast Cancer Risk Reproductive Sciences, January 1, 2009; 16(1): 7 - 19. [Abstract] [PDF]

				C. J. Fabian If Vitamin D Prevents Breast Cancer, How Does It Do It, and How Much Does It Take? ASCO Educational Book, January 1, 2009; 2009(1): 71 - 74. [Abstract] [Full Text] [PDF]

				S. Hansdottir, M. M. Monick, S. L. Hinde, N. Lovan, D. C. Look, and G. W. Hunninghake Respiratory Epithelial Cells Convert Inactive Vitamin D to Its Active Form: Potential Effects on Host Defense J. Immunol., November 15, 2008; 181(10): 7090 - 7099. [Abstract] [Full Text] [PDF]

				C. Diorio, M. Sinotte, J. Brisson, S. Berube, and M. Pollak Vitamin D Pathway Polymorphisms in Relation to Mammographic Breast Density Cancer Epidemiol. Biomarkers Prev., September 1, 2008; 17(9): 2505 - 2508. [Full Text] [PDF]

				T. M. Chlon, D. A. Taffany, J. Welsh, and M. J. Rowling Retinoids Modulate Expression of the Endocytic Partners Megalin, Cubilin, and Disabled-2 and Uptake of Vitamin D-Binding Protein in Human Mammary Cells J. Nutr., July 1, 2008; 138(7): 1323 - 1328. [Abstract] [Full Text] [PDF]

				S. Abbas, J. Linseisen, T. Slanger, S. Kropp, E. J. Mutschelknauss, D. Flesch-Janys, and J. Chang-Claude Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer--results of a large case-control study Carcinogenesis, January 1, 2008; 29(1): 93 - 99. [Abstract] [Full Text] [PDF]

				M. M. Turunen, T. W. Dunlop, C. Carlberg, and S. Vaisanen Selective use of multiple vitamin D response elements underlies the 1 {alpha} ,25-dihydroxyvitamin D3-mediated negative regulation of the human CYP27B1 gene Nucleic Acids Res., April 10, 2007; (2007) gkm179v1. [Abstract] [Full Text] [PDF]

				S. S. Tworoger, I-M. Lee, J. E. Buring, B. Rosner, B. W. Hollis, and S. E. Hankinson Plasma 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D and Risk of Incident Ovarian Cancer Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 783 - 788. [Abstract] [Full Text] [PDF]

				M. J. Rowling, C. M. Kemmis, D. A. Taffany, and J. Welsh Megalin-Mediated Endocytosis of Vitamin D Binding Protein Correlates with 25-Hydroxycholecalciferol Actions in Human Mammary Cells J. Nutr., November 1, 2006; 136(11): 2754 - 2759. [Abstract] [Full Text] [PDF]